Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 27% ± 6% | |
glutamatergic neuron | 3 studies | 42% ± 8% |
Insufficient scRNA-seq data for expression of CACNA1I at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 2890.81 | 645 / 653 | 87% | 7.56 | 529 / 605 |
brain | 92% | 2824.12 | 2425 / 2642 | 55% | 2.67 | 391 / 705 |
adrenal gland | 97% | 1597.28 | 250 / 258 | 29% | 1.46 | 66 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.32 | 1 / 1 |
spleen | 85% | 766.28 | 206 / 241 | 0% | 0 | 0 / 0 |
lung | 38% | 201.58 | 222 / 578 | 20% | 0.49 | 226 / 1155 |
peripheral blood | 53% | 391.50 | 497 / 929 | 0% | 0 | 0 / 0 |
bladder | 29% | 183.24 | 6 / 21 | 22% | 0.81 | 112 / 504 |
stomach | 35% | 156.90 | 125 / 359 | 5% | 0.19 | 15 / 286 |
intestine | 32% | 433.35 | 309 / 966 | 5% | 0.10 | 24 / 527 |
breast | 9% | 38.10 | 40 / 459 | 23% | 0.63 | 253 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.35 | 6 / 29 |
esophagus | 5% | 20.93 | 70 / 1445 | 14% | 0.46 | 26 / 183 |
pancreas | 0% | 0.85 | 1 / 328 | 13% | 0.33 | 23 / 178 |
uterus | 2% | 7.74 | 4 / 170 | 9% | 0.25 | 40 / 459 |
skin | 3% | 9.66 | 49 / 1809 | 6% | 0.16 | 28 / 472 |
kidney | 6% | 52.75 | 5 / 89 | 2% | 0.05 | 16 / 901 |
adipose | 7% | 29.35 | 87 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 7% | 0.31 | 29 / 406 |
prostate | 6% | 23.16 | 14 / 245 | 0% | 0.19 | 2 / 502 |
ovary | 2% | 5.10 | 3 / 180 | 4% | 0.09 | 19 / 430 |
eye | 0% | 0 | 0 / 0 | 3% | 0.14 | 2 / 80 |
blood vessel | 2% | 10.77 | 21 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 2.27 | 5 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.60 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0007165 | Biological process | signal transduction |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_0019228 | Biological process | neuronal action potential |
GO_0030431 | Biological process | sleep |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CACNA1I |
Protein name | Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3) |
Synonyms | KIAA1120 |
Description | FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This channel gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group and are strongly blocked by nickel and mibefradil. A particularity of this type of channels is an opening at quite negative potentials, and a voltage-dependent inactivation. T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle. They may also be involved in the modulation of firing patterns of neurons which is important for information processing as well as in cell growth processes. Gates in voltage ranges similar to, but higher than alpha 1G or alpha 1H (By similarity). . |
Accessions | ENST00000402142.4 [Q9P0X4-1] ENST00000404898.5 [Q9P0X4-4] Q9P0X4 ENST00000401624.5 [Q9P0X4-2] ENST00000407673.5 [Q9P0X4-3] |